REGULATED PRESS RELEASE published on 02/13/2025 at 07:01, 11 months 20 days ago bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes bioMérieux launches GENE-UP® TYPER, an innovative real-time PCR solution for rapid root cause analysis in food industries, targeting Listeria monocytogenes contamination BioMérieux Listeria Monocytogenes GENE-UP® TYPER Real-time PCR Root Cause Analysis
REGULATED PRESS RELEASE published on 02/13/2025 at 07:01, 11 months 20 days ago bioMérieux lance GENE-UP® TYPER, une solution diagnostique innovante destinée aux industries agroalimentaires pour analyser rapidement l’origine des contaminations par Listeria monocytogenes bioMérieux lance GENE-UP® TYPER, solution diagnostique PCR innovante pour identifier rapidement l’origine des contaminations par Listeria monocytogenes dans l'industrie agroalimentaire BioMérieux Listeria Monocytogenes Diagnostic PCR GENE-UP® TYPER Contamination
BRIEF published on 02/11/2025 at 07:06, 11 months 22 days ago BioMérieux : Feu vert de la FDA pour son test de gastroentérite FDA BioMérieux Diagnostic Rapide Gastroentérite BIOFIRE FILMARRAY
BRIEF published on 02/11/2025 at 07:06, 11 months 22 days ago BioMérieux Secures FDA Clearance for Enhanced Gastroenteritis Test BioMérieux FDA Clearance Healthcare Innovation Molecular Diagnostics Gastroenteritis
REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 11 months 22 days ago bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux receives U.S. FDA clearance for the new version of its molecular test, the BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid, targeting causes of gastroenteritis. The test detects 11 common bacteria, viruses, and parasites from one sample in about 1 hour, improving patient outcomes BioMérieux FDA Clearance Gastroenteritis BIOFIRE® FILMARRAY® Molecular Test
REGULATED PRESS RELEASE published on 02/11/2025 at 07:01, 11 months 22 days ago bioMérieux obtient l’autorisation de la FDA américaine pour la nouvelle version de son test moléculaire ciblant les causes de la gastroentérite, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid bioMérieux reçoit l'autorisation de la FDA américaine pour son test moléculaire BIOFIRE® FILMARRAY® Gastrointestinal Panel Mid ciblant la gastroentérite FDA BioMérieux BIOFIRE® Gastroentérite Test Moléculaire
BRIEF published on 02/06/2025 at 11:25, 11 months 27 days ago Biomérieux : Déclaration mensuelle sur les droits de vote et actions Droits De Vote Capital Social BioMérieux Actions 2025
BRIEF published on 02/06/2025 at 11:25, 11 months 27 days ago Biomérieux: Monthly statement on voting rights and shares Share Capital Voting Rights BioMérieux Actions 2025
REGULATED PRESS RELEASE published on 02/06/2025 at 11:20, 11 months 27 days ago Janvier 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux publie les informations mensuelles relatives au nombre total de droits de vote et d'actions conformément à la réglementation financière Droits De Vote Réglementation Financière BioMérieux Actions Informations Mensuelles
BRIEF published on 01/13/2025 at 07:20, 1 year ago BioMérieux à la 43ème J.P. Morgan HealthCare Conference BioMérieux Biologie Moléculaire J.P. Morgan Conference GO•28 Plan Acquisition Spinchip
Published on 02/05/2026 at 13:20, 11 minutes ago Guanajuato Silver Sees Significant Growth in Resources at Valenciana
Published on 02/05/2026 at 13:15, 16 minutes ago Avino Appoints Linda Broughton to The Board of Directors
Published on 02/05/2026 at 13:00, 31 minutes ago Gold Terra Provides Update on Drilling Program Along the Campbell Shear South of the Con Mine, Yellowknife, NWT
Published on 02/05/2026 at 13:00, 31 minutes ago CoTec Notes Portfolio Company HyProMag USA Advances U.S. Hub-And-Spoke Strategy With Arrival of Inserma HDD Pre-Processing Machines at South Carolina and Nevada Sites
Published on 02/05/2026 at 13:04, 27 minutes ago EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 42 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Published on 02/05/2026 at 11:47, 1 hour 44 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:30, 2 hours 1 minute ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 2 hours 1 minute ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 19 hours 27 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 19 hours 27 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 19 hours 46 minutes ago Information concerning the total number of voting rights and shares 2026 01 31